Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SWX/BSLN stock hub

SWX/BSLN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SWX/BSLNis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
669.9M
SIX Swiss Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SWX/BSLN
In the news

Latest news · SWX/BSLN

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.8
P25 n/aP50 n/aP75 n/a
Trailing P/E17.3
P25 n/aP50 n/aP75 n/a
ROE38.5
P25 n/aP50 n/aP75 n/a
ROIC79.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SWX/BSLN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
226
Groups with data
11
Currency
CHF
Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Switzerland
Country code
CH
Employees
189
Employees Change
25%
Employees Change Percent
15.24
Enterprise value
CHF 599.3M
Exchange
SIX Swiss Exchange
Financial currency
CHF
First seen
2026-05-10
Industry
Biotechnology
Isin
CH0011432447
Last refreshed
2026-05-10
Market cap
CHF 669.9M
Price
CHF 54.5
Price currency
CHF
Rev Per Employee
1,229,523.81x
Sector
Healthcare
Sic
2836
Symbol
swx/BSLN
Website
https://www.basilea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
6.01%
EV Earnings
14.89x
EV/EBIT
11.47x
EV/EBITDA
10.65x
EV/FCF
10.08x
EV/Sales
2.58x
FCF yield
8.88%
Forward P/E
12.8x
P/B ratio
5.24x
P/E ratio
17.34x
P/S ratio
2.88x
PE Ratio10 Y
63.74x
PE Ratio3 Y
10.55x
PE Ratio5 Y
23.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
22.48%
EBITDA Margin
23.26%
FCF margin
25.59%
Gross margin
37.51%
Gross Profit
CHF 87.2M
Gross Profit Growth
-20.46%
Gross Profit Growth Q
-32.9%
Gross Profit Growth3 Y
53.45%
Gross Profit Growth5 Y
-2.16%
Net Income
CHF 40.2M
Net Income Growth
-48.14%
Net Income Growth Q
-57.02%
Net Income Growth Years
0%
Net Income Growth5 Y
-6.46%
Pretax Margin
19.74%
Profit Margin
17.32%
Profit Per Employee
CHF 212,910
Profitable Years
4
ROA
12.1
Roa5y
8.66
ROCE
22.45
ROE
38.52
ROIC
79.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

23
MetricValue
Cagr10y
-2.72%
Cagr15y
-1%
Cagr1y
22.63%
Cagr20y
-5.69%
Cagr3y
5.81%
Cagr5y
4.27%
EPS Growth
-46.05
EPS Growth Q
-55.15
EPS Growth Years
0
EPS Growth5 Y
-6.79
FCF Growth
-18.15%
FCF Growth Q
-33.45%
FCF Growth3 Y
85.38%
FCF Growth5 Y
17.16%
OCF Growth
-16.5%
OCF Growth Q
-30.84%
OCF Growth3 Y
81.99%
OCF Growth5 Y
16.63%
Revenue Growth
11.43x
Revenue Growth Q
-2.9x
Revenue Growth Years
3x
Revenue Growth3 Y
15.96x
Revenue Growth5 Y
5.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
CHF 0.86
Assets
CHF 282M
Cash
CHF 159.8M
Current Assets
CHF 251.7M
Current Liabilities
CHF 49.2M
Debt
CHF 89.2M
Debt EBITDA
CHF 1.59
Debt Equity
CHF 0.7
Debt FCF
CHF 1.5
Equity
CHF 127.9M
Interest Coverage
15.56
Liabilities
CHF 154.1M
Long Term Assets
CHF 30.3M
Long Term Liabilities
CHF 104.8M
Net Cash
CHF 70.6M
Net Cash By Market Cap
CHF 10.54
Net Cash Growth
680.74%
Net Debt EBITDA
CHF -1.31
Net Debt Equity
CHF -0.55
Net Debt FCF
CHF -1.19
Tangible Book Value
CHF 127.6M
Tangible Book Value Per Share
CHF 10.38
WACC
6.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.11
Inventory Turnover
5.46
Net Working Capital
CHF 44.8M
Quick ratio
4.53
Working Capital
CHF 202.5M
Working Capital Turnover
CHF 1.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
1.23%
Dividend per share
CHF 0
Last Dividend
CHF 5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-24.09%
1Y total return
22.61%
200-day SMA
51.56
3Y total return
18.48%
50-day SMA
53.65
50-day SMA vs 200-day SMA
50over200
5Y total return
23.25%
All Time High
284.8
All Time High Change
-80.86%
All Time High Date
2007-03-30
All Time Low
28.55
All Time Low Change
90.89%
All Time Low Date
2011-09-15
ATR
1.49
Beta
0.41
Beta1y
0.4
Beta2y
0.78
Ch YTD
-0.37
High
55
High52
59.7
High52 Date
2025-07-29
High52ch
-8.71%
Low
53.8
Low52
42.75
Low52 Date
2025-05-15
Low52ch
27.49%
Ma50ch
1.58%
Price vs 200-day SMA
5.7%
RSI
52
RSI Monthly
59.43
RSI Weekly
54.44
Sharpe ratio
0.74x
Sortino ratio
1.36
Total Return
1.23%
Tr YTD
-0.37
Tr15y
-13.97%
Tr1m
2.83%
Tr1w
-0.55%
Tr3m
-3.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

5
MetricValue
Operating Income
CHF 52.2M
Operating Income Growth
-31.76
Operating Income Growth Q
-46.6
Operating Income Growth5 Y
-5.1
Operating margin
22.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
12,207,789%
Shares Insiders
0.68%
Shares Institutions
34.46%
Shares Out
12,291,580
Shares Qo Q
-2.36%
Shares Yo Y
-1.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
CHF 54.2M
Average Volume
29,880x
Bv Per Share
10.41
CAPEX
CHF -2.6M
Ch10y
-24.09
Ch15y
-21.24
Ch1m
2.83
Ch1w
-0.55
Ch1y
22.61
Ch20y
-71.91
Ch3m
-3.88
Ch3y
18.48
Ch5y
23.25
Ch6m
21.38
Change
0%
Change From Open
0.37
Close
54.5
Days Gap
-0.37
Depreciation Amortization
1,814,000
Dollar Volume
1,428,172.5
Earnings Date
2026-08-18
EBIT
CHF 52.2M
EBITDA
CHF 54.1M
EPS
CHF 3.14
F Score
5
FCF
CHF 59.5M
FCF EV Yield
9.92x
FCF Per Share
CHF 4.84
Financing CF
-21,425,000
Fiscal Year End
December
Founded
2,000
Graham Number
27.68965
Graham Upside
-49.19
Income Tax
CHF 5.6M
Investing CF
-2,862,000
Is Primary Listing
1
Last Earnings Date
2026-02-17
Last Report Date
2025-12-31
Lynch Fair Value
CHF 16.37
Lynch Upside
-69.97
Ma150
52.17
Ma150ch
4.47%
Ma20
54.69
Ma20ch
-0.35%
Net CF
37,777,000
Next Earnings Date
2026-08-18
Open
54.3
P FCF Ratio
11.26
P OCF Ratio
10.79
Position In Range
58.33
Ppne
18,150,000
Price Date
2026-05-08
Price EBITDA
CHF 12.39
Ptbv Ratio
5.25
Relative Volume
0.89x
Revenue
232,380,000x
SBC By Revenue
2.25x
Share Based Comp
5,238,000
Tax By Revenue
2.42x
Tax Rate
12.28%
Tr20y
-69.01%
Tr6m
21.38%
Volume
26,205
Z Score
0.15
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SWX/BSLN pay a dividend?

Capital-return profile for this ticker.

Performance

SWX/BSLN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+22.6%
S&P 500 1Y: n/a
3Y total return
+18.5%
S&P 500 3Y: n/a
5Y total return
+23.2%
S&P 500 5Y: n/a
10Y total return
-24.1%
S&P 500 10Y: n/a
Ownership

Who owns SWX/BSLN?

Insider, institutional, and short-interest positioning.

Institutional ownership
+34.5%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.2%
Negative means the company is buying back shares.
Technical

SWX/BSLN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
52.0
Neutral momentum band
Price vs 200-day MA
+5.7%
50/200-day relationship not available
Beta (5Y)
0.41
Less volatile than the market
Sharpe ratio
0.74
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SWX/BSLN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/BSLN stock rating?

swx/BSLN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/BSLN analysis?

The full report lives at /stocks/swx/BSLN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/BSLN?

The latest report frames swx/BSLN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/BSLN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

swx/BSLN stock profile: metrics, valuation and analysis | शेयर बाज़ार AI एजेंट